Gene · 3872
Papers3,832
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,832
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond. | Cancers (Basel) | 2023 | 37835599 | PubTator, text mining | PubMed |
| Proteomics Profiling of Bladder Cancer Tissues from Early to Advanced Stages Reveals NNMT and GALK1 as Biomarkers for Early Detection and Prognosis of BCa. | Int J Mol Sci | 2023 | 37834386 | PubTator, text mining | PubMed |
| Single-nuclei characterization of pervasive transcriptional signatures across organs in response to COVID-19. | Elife | 2023 | 37830426 | PubTator, text mining | PubMed |
| Precise identification of cell states altered in disease using healthy single-cell references. | Nat Genet | 2023 | 37828140 | PubTator, text mining | PubMed |
| MAPK1 promotes the metastasis and invasion of gastric cancer as a bidirectional transcription factor. | BMC Cancer | 2023 | 37817112 | PubTator, text mining | PubMed |
| Identification of GUCA2A and COL3A1 as prognostic biomarkers in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation. | Sci Rep | 2023 | 37816854 | PubTator, text mining | PubMed |
| A comprehensive review of human trophoblast fusion models: recent developments and challenges. | Cell Death Discov | 2023 | 37816723 | PubTator, text mining | PubMed |
| Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin. | Nat Commun | 2023 | 37805522 | PubTator, text mining | PubMed |
| Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. | J Transl Med | 2023 | 37784157 | PubTator, text mining | PubMed |
| A Tumor in Disguise: Gallbladder Tumor Presenting as Hepatic Abscesses. | Cureus | 2023 | 37779787 | PubTator, text mining | PubMed |
| Spatial transcriptomics in neuroscience. | Exp Mol Med | 2023 | 37779145 | PubTator, text mining | PubMed |
| Regulation of epithelial transitional states in murine and human pulmonary fibrosis. | J Clin Invest | 2023 | 37768734 | PubTator, text mining | PubMed |
| A Route for Investigating Psoriasis: From the Perspective of the Pathological Mechanisms and Therapeutic Strategies of Cancer. | Int J Mol Sci | 2023 | 37762693 | PubTator, text mining | PubMed |
| Molecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer and FDA-Approved Biomarkers. | Int J Mol Sci | 2023 | 37762677 | PubTator, text mining | PubMed |
| Immunohistochemical Staining Characteristics of Low-Grade Invasive Ductal Carcinoma Using the ADH5 Cocktail (CK5/14, P63, and CK7/18): A Potential Interpretative Pitfall. | Diagnostics (Basel) | 2023 | 37761331 | PubTator, text mining | PubMed |
| Tumor Infiltrating Lymphocytes (TILS) and PD-L1 Expression in Breast Cancer: A Review of Current Evidence and Prognostic Implications from Pathologist's Perspective. | Cancers (Basel) | 2023 | 37760449 | PubTator, text mining | PubMed |
| Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17A. | Clin Cosmet Investig Dermatol | 2023 | 37752969 | PubTator, text mining | PubMed |
| Tertiary lymphoid structure and neutrophil-lymphocyte ratio coordinately predict outcome of pembrolizumab. | Cancer Sci | 2023 | 37752769 | PubTator, text mining | PubMed |
| The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia. | J Oral Pathol Med | 2023 | 37749621 | PubTator, text mining | PubMed |
| Novel Insights into Circular RNAs in Metastasis in Breast Cancer: An Update. | Noncoding RNA | 2023 | 37736901 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3872/papers?page=19